RUNX2
DiscoveriesNew cancer drug may reverse midlife bone loss and weight gain
CADD522 preserved fragile bone architecture and cut fat in menopausal mice, but the potential treatment remains years from human use.
Joshua Shavit
CADD522 preserved fragile bone architecture and cut fat in menopausal mice, but the potential treatment remains years from human use.
Joshua Shavit